Search PDMR transactions

Notifier
Name of person with notification obligation
BioAll AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Mathias Svahn
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
No
Amendment
Yes
Details of amendment
Fel transaktionskaraktär angiven
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share NextCell Pharma AB SE0009723125 Exercise increase 62,894 Quantity 1.00 SEK 30/05/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma AB SE0009723125 Exercise increase 30/05/2025 Outside a trading venue 62,894 (Quantity) 1.00 SEK
Total: 62,894
<< Back